DAFNA Capital Management »

Neumora Therapeutics shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $137k 70k 1.95

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Stereotaxis Com New (STXS)
Day One Biopharmaceuticals I (DAWN)
AtriCure (ATRC)
Ideaya Biosciences (IDYA)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Compass Pathways Sponsored Ads (CMPS)
Nektar Therapeutics Com New (NKTR)
Ishares Nasdaq Biotech Indx Etf (IBB)
Arcus Biosciences Incorporated (RCUS)
Neurocrine Biosciences (NBIX)
Larimar Therapeutics (LRMR)
Bicara Therapeutics (BCAX)

View all positions for DAFNA Capital Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
Siren
Perceptive Advisors
Vanguard Group
MIC Capital Management UK
Vanguard Capital Management
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Millennium Management
ICONIQ Capital
Lunate Capital
BlackRock
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies

View all funds holding Neumora Therapeutics